A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight (NCT07745504)
A Placebo-controlled Comparability Study to Compare Two Presentations of Cagrilintide for Weight Management in Participants With Overweight or Obesity
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this clinical study is to look at how well a study medicine called cagrilintide helps people living with excess body weight to lose weight. Participants will either get cagrilintide, the active study medicine being tested or placebo, a medicine that has no active medicine in it. Which treatment participants get is decided by chance. Cagrilintide is a new medicine under development that doctors cannot prescribe yet, but it has been tested in humans before. Participants will be in this clinical study for about 9 months.
Who can join: Review the eligibility criteria below.
Location: Hope Clin Res & Wellness — Conyers, Georgia
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (36 Sites)
Showing the first 25 of 36 sites.
- Hope Clin Res & Wellness — Conyers, Georgia
- East West Med Res Inst — Honolulu, Hawaii
- Walgreens - Store 11760 — Oak Park, Illinois
- Midwest Inst For Clin Res — Indianapolis, Indiana
- The Alliance for Multispecialty Research LLC AMR — Lexington, Kentucky
- PharmQuest — Greensboro, North Carolina
- KDCILM, LLC & Accellacare US, Inc. — Wilmington, North Carolina
- Coastal Carolina Res Ctr — North Charleston, South Carolina
- Health Res of Hampton Roads — Newport News, Virginia
- National Clin Res Inc. — Richmond, Virginia
- Selma Medical Associates — Winchester, Virginia
- General Hospital Of Athens Alexandra - Department of Endocrinology, Diabetes Center — Athens,
- General Hospital Of Athens G Gennimatas - Department of Endocrinology — Athens,
- General Hospital Venizeleio-Pananeio - Diabetic Clinic — Irakleio,
- Athens Medical Center S.A. (Iatriko Peristeriou) - Diabetes, obesity and cardiometabolic diseases department — Peristeri,
- Ippokratio General Hospital Of Thessaloniki - B' Internal Medicine clinic — Thessaloniki,
- St. Luke's Hospital S.A. - Endocrinology Department and Obesity Clinic — Thessaloniki,
- Stúdium Egészségház Kft. — Kalocsa, Bács-Kiskun county
- Borbánya Praxis E.Ü. Kft. — Nyíregyháza, Szabolcs-Szatmar Varmegye
- Trial Pharma Kft. — Kecskemét,
- KomplexLabor Diagnosztika Kft. — Szeged,
- ULS Do Oeste E.P.E. - Unidade Caldas da Rainha_CAMI - Unidade de Diabetes — Caldas da Rainha,
- ULS Do Baixo Mondego, E.P.E. - HDFF_Serviço Cirurgia (Esp. Endocrinologia) — Figueira da Foz Municipality,
- Hospital São Francisco, S.A_EECC — Leiria,
- APDP - Associação Protectora dos Diabéticos de Portugal — Lisbon,
📞 Contact the Study Coordinator
Phone: (866) 867-7178
Email: clinicaltrials@novonordisk.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overweight
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes — Northridge, California
- A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight — Tempe, Arizona
- A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity — Tempe, Arizona
- Partnerships for Reducing Overweight and Obesity with Patient-Centered Strategies 2.0 — Boston, Massachusetts
- Impact of Metabolic Health on Sperm Epigenetic Marks in Humans — Boston, Massachusetts
- The Effects of Almond Consumption on Functional Performance and Activity in Overweight Active Older Adults — Tallahassee, Florida
Explore by condition: All Overweight clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.